Trial Details

COMPLETED
Basic Information
Clinical ID c1491
Identifier NCT02550418
Trial Title Budesonide 9 mg Capsules in Active UC
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Colitis, Ulcerative
Interventions DRUG: Budesonide
Participant Information
Sponsor Dr. Falk Pharma GmbH
City Lübeck
Country/Region Germany
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2025-10-15
Primary Completion Date 2025-03-17
Completion Date 2025-03-17